Search
for
Sort by
Research 61–90 of 1000+
- A Case Report of Male Systemic Lupus Erythematous with Antinuclear Antibodies-Negative: A Challenging Diagnosis
- 272 Structural changes in human skin after topical application of glucocorticoids assessed by in vivo imaging technologies
- New-onset systemic lupus erythematosus during pregnancy: A challenge in diagnosis
- Generalised Glucocorticoid Resistance
- Autoamputation in a 45-Year-Old Female with Systemic Lupus Erythematosus Overlap with Systemic Sclerosis: A Case Report
- A Case Report of Autoimmune Hemolytic Anemia with Deep Vein Thrombosis in a 16-year-old Girl - Is It Systemic Lupus Erythematosus?
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- Fever and rash as initial signs of systemic autoimmune disease. Case Report.
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Retrospective Analysis of Systemic Corticosteroids for Alopecia Areata in Pediatric Patients
- Systemic corticosteroids in vitiligo: Evidence-based insights and practical considerations
- Characteristics of pregnancy with Systemic Lupus Erythematosus (SLE) in Dr. Mohammad Hoesin Hospital, Palembang
- Acne and Systemic Disease
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- A clinical study of pemphigus vulgaris and its variants, evaluation of safety and efficacy of glucocorticoids versus immunosuppressants at tertiary care hospital: a study of 75 cases
- Low Free Thyroxine (FT4) in critically ill juvenile systemic lupus erythematosus: a diagnostic approach
- 258 11β-hydroxysteroid dehydrogenase type 1 inhibition attenuates the adverse effects of glucocorticoids on dermal papilla cells
- Acne as a chronic systemic disease
- Skin signs of systemic diseases
- Topical absorption and systemic toxicity
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Effects of local and systemic medications on eye health: Adverse reactions
- Update on the dermatologic use of systemic glucocorticosteroids
- Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases